Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic

Annals of Allergy, Asthma and Immunology

Volumn 113, Issue 6, 2014, Pages 619-623

  Laforce, Craig ^a   Brooks, Elizabeth ^b   Herje, Nancy ^c   Dorinsky, Paul ^d   Rickard, Kathy ^c  

^a North Carolina Clinical Research Inc   (United States)

^b Reimbursement Principles   (United States)

^c Kainos Medicine USA Inc   (United States)

^d Cipla   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; ANTIASTHMATIC AGENT; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; COST EFFECTIVENESS ANALYSIS; FEMALE; FRACTION OF EXHALED NITRIC OXIDE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCRIPTION; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; SYMPTOMATOLOGY; BIOSYNTHESIS; BREATH ANALYSIS; CLINICAL TRIAL; ECONOMICS; EXHALATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; TH2 CELL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; EXHALATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; SPIROMETRY; TH2 CELLS; TREATMENT OUTCOME;

EID: 84919843944     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.06.013     Document Type: Article

References (28)

1. E.D. Bateman, S.S. Hurd, and P.J. Barnes Global strategy for asthma management and prevention: GINA executive summary Eur Respir J 31 2008 143 178
2. R.A. Dweik, P.B. Boggs, and S.C. Erzurum An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications Am J Respir Crit Care Med 184 2011 602 615
3. National Asthma Education and Prevention Program: Expert Panel Report 3 2007 US Department of Health and Human Services, National Heart, Blood, and Lung Institute Bethesda, MD
4. P.J. Barnes, R.A. Dweik, and A.F. Gelb Exhaled nitric oxide in pulmonary diseases: a comprehensive review Chest 138 2010 682 692
5. E.J. Peirsman, T.J. Carvelli, and P.Y. Hage Exhaled nitric oxide in childhood allergic asthma management a randomised controlled trial Pediatr Pulmonol 49 2014 624 631
6. A.D. Smith, J.O. Cowan, and S. Filsell Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests Am J Respir Crit Care Med 169 2004 473 478
7. J. Syk, A. Malinovschi, and G. Johansson Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial J Allergy Clin Immunol Pract 1 2013 639 648
8. D.R. Taylor, M.W. Pijnenburg, A.D. Smith, and J.C. De Jongste Exhaled nitric oxide measurements: clinical application and interpretation Thorax 61 2006 817 827
9. Zitt M. AAAAI/ACAAI joint statement of support of the ATS clinical practice guideline: interpretation of exhaled nitric oxide for clinical applications. 2012. Http://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/My%20Membership/FeNOJointStatement3-6-12.pdf. Accessed July 18, 2014.
10. A.F. Gelb, C. Flynn Taylor, C.M. Shinar, C. Gutierrez, and N. Zamel Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics Chest 129 2006 1492 1499
11. R.S. Zeiger, M. Schatz, and F. Zhang Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids J Allergy Clin Immunol 128 2011 412 414
12. R.A. Nathan, C.A. Sorkness, and M. Kosinski Development of the asthma control test: a survey for assessing asthma control J Allergy Clin Immunol 113 2004 59 65
13. L.J. Akinbami, J.E. Moorman, and X. Liu Asthma prevalence, health care use, and mortality: United States, 2005-2009 Natl Health Stat Rep 32 2011 1 14
14. F. Andersson, E. Stahl, and P.J. Barnes Adding formoterol to budesonide in moderate asthma-health economic results from the FACET study Respir Med 95 2001 505 512
15. S.B.L. Barnett, and T.A. Nurmagambetov Costs of asthma in the United States: 2002-2007 J Allergy Clin Immunol 127 2011 145 152
16. R.H. Green, C.E. Brightling, and S. McKenna Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721
17. L. Jayaram, M.M. Pizzichini, and R.J. Cook Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Eur Respir J 27 2006 483 494
18. A.D. Smith, J.O. Cowan, K.P. Brassett, G.P. Herbison, and D.R. Taylor Use of exhaled nitric oxide measurements to guide treatment in chronic asthma N Engl J Med 352 2005 2163 2173
19. A. Szende, K. Svensson, E. Ståhl, A. Mészáros, and G.Y. Berta Psychometric and utility-based measures of health status of asthmatic patients with different disease control level Pharmacoeconomics 22 2004 537 547
20. A. Ozier, P.-O. Girodet, I. Bara, J.-M. Tunon de Lara, R. Marthan, and P. Berger Control maintenance can be predicted by exhaled NO monitoring in asthmatic patients Respir Med 105 2011 989 996
21. D.R. Taylor Biomarkers of inflammation in asthma: a clinical perspective Semin Respir Crit Care Med 33 2012 620 629
22. F. Volbeda, M. Broekema, and M.E. Lodewijk Clinical control of asthma associates with measures of airway inflammation Thorax 68 2013 19 24
23. M.W. Pijnenburg, E.M. Bakker, W.C. Hop, and J.C. De Jongste Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial Am J Respir Crit Care Med 172 2005 831 836
24. I. Agache, and C. Ciobanu Predictive value of lung function trend and FeNO for difficult asthma in children J Investig Allergol Clin Immunol 22 2012 419 426
25. R.A. Dweik, R.L. Sorkness, and S. Wenzel Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma Am J Respir Crit Care Med 181 2010 1033 1041
26. I.H. Van Veen, A. Ten Brinke, and P.J. Sterk Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Eur Respir J 32 2008 344 349
27. J.F. Donohue, and N. Jain Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates Respir Med 107 2013 943 952
28. H. Powell, V.E. Murphy, and D.R. Taylor Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial Lancet 378 2011 983 990